Pancreas specific expression of oncogenes in a porcine model
Tóm tắt
Pancreatic cancer is the fourth leading course of cancer death and early detection of the disease is crucial for successful treatment. However, pancreatic cancer is difficult to detect in its earliest stages and once symptoms appear, the cancer has often progressed beyond possibility for curing. Research into the disease has been hampered by the lack of good models. We have generated a porcine model of pancreatic cancer with use of transgenic overexpression of an oncogene cassette containing MYC, KRAS
G12D and SV40 LT. The expression was initiated from a modified Pdx-1 promoter during embryogenesis in a subset of pancreatic epithelial cells. Furthermore, cells expressing the oncogenes also expressed a yellow fluorescent protein (mVenus) and an inducible negative regulator protein (rtTR-KRAB). Cells where the Pdx-1 promoter had not been activated, expressed a red fluorescent protein (Katushka). In vitro analyses of cells obtained from the transgenic pigs showed increased proliferation and expression of the transgenes when activated. Induction of the repressor protein eliminated the oncogene expression and decreased cell proliferation. In vivo analysis identified foci of pancreatic cells expressing the oncogenes at day zero post farrowing. These populations expanded and formed hyperplastic foci, with beginning abnormality at day 45. Cells in the foci expressed the oncogenic proteins and the majority of the cells were positive for the proliferation marker, Ki67. We predict that this model could be used for advanced studies in pancreatic cancer in a large animal model with focus on early detection, treatment, and identification of new biomarkers.
Tài liệu tham khảo
Ai HW, Henderson JN, Remington SJ, Campbell RE (2006) Directed evolution of a monomeric, bright and photostable version of Clavularia cyan fluorescent protein: structural characterization and applications in fluorescence imaging. Biochem J 400:531–540. doi:10.1042/bj20060874
Alexopoulou AN, Couchman JR, Whiteford JR (2008) The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol 9:2. doi:10.1186/1471-2121-9-2
Biankin AV et al (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491:399–405. doi:10.1038/nature11547
Bollen P, Ellegaard L (1997) The Gottingen minipig in pharmacology and toxicology. Pharmacol Toxicol 80(Suppl 2):3–4
Chang DK, Grimmond SM, Biankin AV (2014) Pancreatic cancer genomics. Curr Opin Genet Dev 24:74–81. doi:10.1016/j.gde.2013.12.001
Goedhart J et al (2012) Structure-guided evolution of cyan fluorescent proteins towards a quantum yield of 93%. Nat Commun 3:751. doi:10.1038/ncomms1738
Gopinathan A, Morton JP, Jodrell DI, Sansom OJ (2015) GEMMs as preclinical models for testing pancreatic cancer therapies. Dis Models Mech 8:1185–1200. doi:10.1242/dmm.021055
Haschek WM, Rousseaux CG, Wallig MA, Bolon B, Ochoa R, Mahler BW (2013) Haschek and Rousseaux’s handbook of toxicologic pathology, 3rd edn. Academic Press, Amsterdam
Hasegawa K, Cowan AB, Nakatsuji N, Suemori H (2007) Efficient multicistronic expression of a transgene in human embryonic stem cells. Stem Cells 25:1707–1712. doi:10.1634/stemcells.2006-0813
Jakobsen JE et al (2011) Pig transgenesis by Sleeping Beauty DNA transposition. Transgenic Res 20:533–545. doi:10.1007/s11248-010-9438-x
Jakobsen JE et al (2013) Generation of minipigs with targeted transgene insertion by recombinase-mediated cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT). Transgenic Res 22:709–723. doi:10.1007/s11248-012-9671-6
Kragh PM et al (2009) Hemizygous minipigs produced by random gene insertion and handmade cloning express the Alzheimer’s disease-causing dominant mutation APPsw. Transgenic Res 18:545–558. doi:10.1007/s11248-009-9245-4
Lunney JK (2007) Advances in swine biomedical model genomics. Int J Biol Sci 3:179–184
Matsunari H et al (2014) Transgenic pigs with pancreas-specific expression of green fluorescent protein. J Reprod Dev 60:230–237
Michl P, Gress TM (2013) Current concepts and novel targets in advanced pancreatic cancer. Gut 62:317–326. doi:10.1136/gutjnl-2012-303588
Morton JP et al (2010) Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer. Proc Natl Acad Sci USA 107:246–251. doi:10.1073/pnas.0908428107
Raymond CS, Soriano P (2007) High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2:e162. doi:10.1371/journal.pone.0000162
Sakorafas GH, Tsiotou AG, Tsiotos GG (2000) Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective. Cancer Treat Rev 26:29–52. doi:10.1053/ctrv.1999.0144
Samuel N, Hudson TJ (2011) The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol Hepatol 9:77–87. doi:10.1038/nrgastro.2011.215
Schmidt M et al (2010) Pregnancies and piglets from large white sow recipients after two transfer methods of cloned and transgenic embryos of different pig breeds. Theriogenology 74:1233–1240. doi:10.1016/j.theriogenology.2010.05.026
Shcherbo D et al (2007) Bright far-red fluorescent protein for whole-body imaging. Nat Methods 4:741–746. doi:10.1038/nmeth1083
Szulc J, Wiznerowicz M, Sauvain MO, Trono D, Aebischer P (2006) A versatile tool for conditional gene expression and knockdown. Nat Methods 3:109–116. doi:10.1038/nmeth846
Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620. doi:10.1016/s0140-6736(10)62307-0
Yachida S et al (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467:1114–1117. doi:10.1038/nature09515
Zuber J et al (2011) An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev 25:1628–1640. doi:10.1101/gad.17269211